Menu
Merck
Merck has announced its third round this year of refunds to 340B covered entities for overcharges on select products.

Merck Announces Third Round of 340B Refunds for 2019 Drug Purchases

In Federal, Pharma Industry, Regulatory122 Views Tom Mirga

Drug manufacturer Merck has announced its third round this year of refunds to 340B covered entities for overcharges on select products.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report